“…Subsequently, similar results have been obtained in a variety of liver injury models [74,132,133], including the above mentioned Alb-uPA [73,75] mice as well as fumarylacetoacetate hydrolase knockouts (FAH −/− mice) [76,124], mice expressing a fusion protein of the FK506 binding protein and caspase 8 under control of the albumin promoter (AFC8 mice) [74], mice expressing uPA under the promoter for major urinary protein (MUP-uPA mice) [135], and mice expressing herpes simplex virus thymidine kinase (HSV-TK) [136]. These human-liver chimeric mice support infection with a variety of hepatotropic pathogens, including HBV, HCV, HDV, and most recently HEV [73,76,124,[137][138][139][140][141][142][143]. These mice have been used to study innate host responses to many hepatitis viruses, including HCV, and for testing the efficacy of novel therapeutic regimens; however, the highly immunocompromised status of these human-liver chimeric mice precludes the study of immune-mediated pathogenesis by HCV.…”